UiPath cofounder and CEO Daniel Dines goes deep on the machinery under the platform – the Temporal engine that lets an ...

To our knowledge, this study is the first to apply deep learning models that can, beyond diagnosis, identify molecular subtypes and predict outcomes in a single brain tumour entity (meningioma) using ...